TITLE

German drugs researchers face axe

AUTHOR(S)
Gibson, Jane
PUB. DATE
January 2007
SOURCE
ICIS Chemical Business;1/29/2007, Vol. 2 Issue 51, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article unveils the plan of German drug makers to reduce their workforce in 2007. The plans were raised in relation to the expected lower sales and earnings in the country. According to a survey, several companies will reduce their research and development (R&D) spending. Another study concluded that staff reductions in the country's drugs sector is related to the global industry consolidation and changing job profiles.
ACCESSION #
23977789

 

Related Articles

  • Lilly braces for plunge in profits. Wall, J. K. // Indianapolis Business Journal;8/16/2010, Vol. 31 Issue 24, p1 

    The article reports on the efforts of pharmaceutical company Eli Lilly & Co. to prepare for the projected decline in profits. The author mentions that the company is facing expirations of several drug patents and loss of revenue. One analyst forecasts that the company will lose 4.3 billion...

  • Do's and Don'ts of Downsizing. Grant, Susan; Cherkis, Carol // Pharmaceutical Executive;May2003, Vol. 23 Issue 5, p102 

    Reports on the importance of business planning in handling corporate downsizing among pharmaceutical companies in the U.S. Advantage of positive industrial relations; Preparation for employee retrenchment; Executive training to conduct layoffs. INSETS: Step by Step;Breaking the News.

  • Palatin to Cut Jobs. Gaudio, Thomas // njbiz;5/19/2008, Vol. 21 Issue 21, p2 

    The article reports on a plan by Cranbury, New Jersey-based biopharmaceutical firm Palatin Technologies Inc. to reduce its work force by 30 percent, as of May 2008. Palatin aims to align its human resources with its new strategic objectives. The company has changed the focus of developing one of...

  • Novartis scales down sales force.  // Pharmaceutical Representative;Dec2007, Vol. 37 Issue 12, p10 

    The article reports on the move of Novartis AG to reduce its U.S. pharmaceuticals organization. The plan was initiated following the suspension of Zelnorm in March 2007, as well as the rise of generic competition for its Lotrel, Lamisil, Famvir brands. A total of 1,260 positions will be...

  • Nanometrics reduces workforce by 7%. Mutschler, Ann Steffora // Electronic News;1/21/2008, Vol. 54 Issue 3, p21 

    This article reports on the plan of semiconductor metrology company Nanometrics Inc. to reduce its global workforce in order to maintain profitability. cash flow and predictability. This reduction will impact employees in each of the company's locations and the company will record approximately...

  • Surviving in a downsizing world. Kidder, Pamela J.; Ryan, Bobbie // Journal for Quality & Participation;Jan96, Vol. 19 Issue 1, p94 

    Part II. Presents exercises on business planning. Tips on long-range planning; Extrinsic and intrinsic values in the workplace; Tips on surviving downsizing for companies.

  • Understanding the Chinese Market. Songjun Luo; Chapman, Brian // European Pharmaceutical Executive;Oct2007, p30 

    The article reports on the market performance of the pharmaceutical industry in China. Assessment of the country's pharmaceutical market potential at the hospital level reveals several valuable insights into the market potential distribution. The author presented the number of cities that...

  • Job cuts as confidence and orders fall.  // Personnel Today;5/13/2003, p8 

    Manufacturing employers expect to make 86,000 job cuts in the first half of 2003, as a result of declining business confidence and orders throughout every region of Great Britain. The regional survey of British manufacturing, published quarterly by the Career Beliefs Inventory and Experian...

  • PROFITS WITHOUT PEOPLE. Miller, Karen Lowry // Bulletin with Newsweek;11/15/2003, Vol. 121 Issue 6400, p54 

    Market forecasters are on the edge because U.S. companies typically start creating jobs three months after a downturn, but in the 23 months since the official end of the U.S. recession nearly 2 million more jobs have disappeared. Even the U.S. economy surprisingly strong third-quarter showing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics